medline.ch Dermatologie Tumoren Melanom

	ChronoimmunoTOX: A Single-Institution Retrospective Study on How the Time of Administration Impacts Immune Checkpoint Inhibitor Efficacy and Toxicity in Melanoma. J Clin Med Nepote A, Burghgraeve G, Pedrani M, Gomez Ramos AJ, Saporita I, Spataro V, Espeli V, Pereira Mestre R, Sangiolo D, Imbimbo M, Mangas C. PMID: 41517320 [PubMed]
	Utility of High-Frequency Ultrasound in Preoperative Evaluation of the Thickness of Cutaneous Melanoma. Diagnostics (Basel) Zhao Y, Yang F, Li D, Wang Q, Guo L, Ren W, Shan D, Qin C. PMID: 41515666 [PubMed]
	MicroRNAs as Diagnostic and Prognostic Biomarkers in Melanoma and Non-Melanoma Skin Cancers: An Updated Review. Diagnostics (Basel) Oiegar A, Tigu AB, Baican A, Candrea E, Negrutiu M, Danescu S. PMID: 41515546 [PubMed]
	Investigating Chronic Toxicity, Diet, Patient-Reported Outcomes and the Microbiome in Immunotherapy-Treated Metastatic Melanoma Survivors: A New Frontier. Nutrients Robert M, Saha S, Dizman N, Rohlfs M, Sirmans E, Simon J, Amaria RN, Glitza Oliva IC, Tawbi HA, Davies MA, Ikeguchi A, Basen-Engquist K, Schadler K, Roth ME, Song W, Zhang X, Ajami NJ, Cohen L, Wargo JA, Peterson CB, McQuade JL, Daniel CR. PMID: 41515159 [PubMed - indexed for MEDLINE]
	Metastatic Uveal Melanoma Surveillance: A Delphi Panel Consensus. Cancers (Basel) Alban J, Bowen RC, Reichstein DA, McKean M, Lutzky J, Weis E, Carvajal RD, Dulka S, Morse BG, Butler MO, Rapisuwon S, Kim KB, Chandrasekaran S, Warner AB, Zager JS, Chmielowski B, Patel SP, Hernandez-Aya LF, Correa ZM, Fecher LA, Najjar YG, Montazeri K, Shoushtari AN, Javed A, Gombos DS, Salama AKS, Tsai K, Miller FH, Khushalani N, Seedor RS, Lipson EJ, Reddy SA, Buchbinder E, Bhatia S, Pavlick A, Mehmi I, Aaberg T, Ikeguchi AP, Kim IK, Walter SD, Singh AD, Sullivan RJ, Choi JS, Williams BK Jr, Orloff M, Mruthyunjaya P, Schollenberger MD, Gandhi N, Harbour JW, Chandra S. PMID: 41514630 [PubMed]
	Medical support platform for melanoma analysis and detection based on federated learning. Sci Rep Laso S, Herrera JL, Flores-Martin D. PMID: 41513722 [PubMed - as supplied by publisher]
	Advances in melanoma immunotherapy: harnessing vaccination as a potential novel immunotherapeutic strategy. Biochem Pharmacol Abuelainain D, Abdel-Aziz AK, Saadeldin MK. PMID: 41513106 [PubMed - as supplied by publisher]
	Diagnostic accuracy of reflectance confocal microscopy for acral lentiginous melanoma. JAAD Case Rep Milovanovic U, Pan A, Laborada J, Lam L, Ottuso P, Ravichandran S, Correa-Selm L. PMID: 41509666 [PubMed]
	Risk Factors for Melanoma Survival: DGCR8 as a Predictive Factor for Mortality in Young Patients. Acta Derm Venereol Schafer F, Bellolio E, Sepúlveda T, Espinoza M, Orellana JJ, Villaseca MA, Miranda R. PMID: 41508836 [PubMed - indexed for MEDLINE]
	Real-world evaluation of the use of melanoma risk prediction tools by clinicians in Australia: a mixed methods study. Br J Dermatol Reyes-Marcelino G, Salam RA, Espinoza D, Watts CG, Steinberg J, Kang YJ, Martin LK, Guitera P, Lo SN, Varey AHR, Scolyer RA, Long GV, Smit AK, Cust AE. PMID: 41507070 [PubMed - as supplied by publisher]
	Targeting the microbiota-miRNA-protease axis: A new therapeutic avenue in melanoma. FEBS J Katsoulieris EN, Ioannou P, Afratis NA. PMID: 41506657 [PubMed - as supplied by publisher]
	Phase II trial of interleukin-12 followed by interferon alfa-2b in patients with metastatic malignant melanoma: Results from CALGB 500001 (Alliance). Cancer Immunol Res Liu A, Johnson C, Niedzwiecki D, Relation T, Yarlagadda S, Gajewski TF, Carson WE. PMID: 41505731 [PubMed - as supplied by publisher]
	Association between GRIm score and response to nivolumab monotherapy in patients with advanced malignant melanoma. J Cancer Res Clin Oncol Oksuz S, Kinikoglu O, Ozkerim U, Isik D, Surmeli H, Ay S, Gundogdu UD, Basoglu T, Odabas H, Turan N. PMID: 41504775 [PubMed - indexed for MEDLINE]
	Phase III Study Investigating the Safety and Efficacy of TM5614 in Combination With Nivolumab for the Treatment of Unresectable Malignant Melanoma: Protocol. Exp Dermatol Fujimura T, Yoshino K, Kato H, Fukushima S, Fujisawa Y, Matsushita S, Uhara H, Rokunohe D, Takenouchi T, Maekawa T, Nakamura Y, Namikawa K, Takahashi A, Yoshikawa S, Iwata H, Yamasaki O, Uchi H, Ohno F, Ito T, Tanemura A, Ohe S, Yamazaki E, Takahashi-Watanabe M, Muto Y, Kambayashi Y, Hashimoto A, Asano Y. PMID: 41504650 [PubMed - indexed for MEDLINE]
	LCSD-Net: a light-weight cross-attention-based semantic dual transformer for domain generalization in melanoma detection. J Med Imaging (Bellingham) Agrawal R, Gupta N, Jalal AS. PMID: 41503367 [PubMed]
	Acral Lentiginous Melanoma of the Hand: Diagnostic Pitfalls and Margin Management Strategies. Plast Reconstr Surg Glob Open Abella M, Kuschner S, Krajisnik A, Amersi F, Kulber D. PMID: 41503202 [PubMed]
	Five-year survival after introduction of adjuvant treatment in stage III melanoma: A nationwide registry-based study. Eur J Cancer Helgadottir H, Ny L, Ullenhag GJ, Mikiver R, Isaksson K, Olofsson Bagge R. PMID: 41500895 [PubMed - as supplied by publisher]
	Tumour control, eye retention and visual acuity after radiotherapy for choroidal melanoma. BMJ Open Ophthalmol Murtagh P, O'Riordan MM, O'Neill V, Cunningham M, D'Arcy F, Eleuteri A, Greene A, Baily C, Kennedy S, Hussain R, Heimann H, Horgan N. PMID: 41500613 [PubMed - indexed for MEDLINE]
	Oncologic and Surgical Outcomes of Head and Neck Non-Melanoma Skin Cancer: A Systematic Review and Meta-Analysis of Wide Local Excision Versus Mohs Micrographic Surgery. J Cutan Med Surg Nukaly HY, Alghamdi AM, Aljohani AG, Almaghrabi M, Aljuhani JA, Alqazenli M, Ezzi S, Barnawi G, Alturkistani T, Jfri A, Litvinov IV. PMID: 41499252 [PubMed - as supplied by publisher]
	Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Stage IV Melanoma Receiving Immune Checkpoint Inhibitors: A Single-Center Retrospective Study. J Dermatol Horisaki K, Yoshikawa S, Omata W, Tsutsumida A, Kiyohara Y. PMID: 41496663 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 44783

Seite 1 von 2240

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung